Shanghai Menon Animal Nutrition Technology Co. Ltd. (301156) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Shanghai Menon Animal Nutrition Technology Co. Ltd. stock ¥3.32, price ¥10.38, that is 68.0% below the price, quality 47 out of 100. Rating: strongly overvalued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 5, 2026.
How to read this chart
53‑month range ¥5.56 – ¥23.31 · fair‑value band ¥2.69 – ¥4.46 · the ¥10.38 price screens above the ¥3.32 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 5, 2026.
Follow Shanghai Menon Animal Nutrition Technology Co. in your weekly email
Every Wednesday you see whether Shanghai Menon Animal Nutrition Technology Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Shanghai Menon Animal Nutrition Technology Co., Ltd. engages in the research and development, production, and sale of feed additives and enzymatic protein feed raw materials in China.
Show moreShow less
It offers food attractants, sweeteners, acidulants, plant extracts, sodium butyrate, butyric acid glyceride, emulsifiers, small peptides, etc.
The company also provides fragrance, acidity regulator, flavoring agents, slow-release nitrogen sources, rumen-bypass amino acids, rumen-pass vitamins, and mineral elements, as well as enzymatic hydrolysis of vegetable protein.
Its products are used in animal breeding fields such as pigs, ruminants, poultry, and aquatic products. The company also exports its products to Asia, Europe, North America, South America, Africa, Oceania, and internationally.
Shanghai Menon Animal Nutrition Technology Co., Ltd. was founded in 1997 and is based in Shanghai, China.
Stock analysis
Shanghai Menon Animal Nutrition Technology Co. Ltd. (301156) currently trades at ¥10.38, while our model-based Fair Value estimate is ¥3.32, 68% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ¥6.69 per share, and 1 of the 16 models we run sit above the ¥10.38 price.
Bear case: the Asset-Based group reads lowest at ¥1.70, and 15 of the 16 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ¥2.69 (bear) to ¥4.46 (bull), the price of ¥10.38 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 47/100 (below-average quality), in the Consumer Defensive sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Shanghai Menon Animal Nutrition Technology Co. Ltd. reported revenue of 561M CNY in FY2025 versus 546M CNY in FY2021, a compound +0.7%/yr. Reported net income was 54.8M CNY in FY2025, compounding −6.1%/yr from FY2021.
Key figures
Market cap 1.9B CNY (≈ $285M) Micro · P/E ratio 38.4 · P/S ratio 2.91 · EPS (TTM) ¥0.2700 · Dividend yield 1.3% · Net margin 7.6% · Return on equity 6.9% · Return on assets (EBIT) 8.8% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).
What moves the price
The share trades about 35% below its 52-week high and 4% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at −1% fair-value upside, at −68%, 301156 screens richer than that median.
Fair Value models
Bear¥2.69Fair Value ¥3.32Bull¥4.46
Price ¥10.38 · Downside -68.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (¥0.1192 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Residual Income¥3.16¥3.33¥3.6376
EPV¥3.55¥3.91¥4.2274
ROIC Compounder¥3.55¥3.91¥4.4672
All 16 models by family
Earnings-Based
Graham-Dodd¥2.02¥6.64¥8.8864
Lynch FV¥1.49¥2.13¥2.7761
PEG = 1.0¥1.49¥2.13¥2.7757
EPV¥3.55¥3.91¥4.2274
Dividend Discount
Gordon GGM¥1.99¥3.70¥5.2567
DDM Multi-Stage¥1.99¥3.21¥3.9467
Multiples
P/E Multiple¥4.69¥6.25¥7.8163
P/S Multiple¥3.66¥4.88¥6.1058
P/B Multiple¥14.91¥19.87¥24.8455
EV/EBIT¥5.70¥7.13¥8.5666
EV/EBITDA¥6.12¥7.69¥9.2667
EV/Revenue¥4.48¥5.79¥7.1054
Asset-Based
NCAV (Graham)¥1.12¥1.70¥2.1354
Economic Profit
Residual Income¥3.16¥3.33¥3.6376
ROIC Compounder¥3.55¥3.91¥4.4672
Growth Earnings
Growth-Adj P/E¥3.95¥5.64¥7.3467
The fair value above starts from this blend and is adjusted for dilution from new shares.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.33/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+14.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.9%
Start year 2020 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.3%
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−12.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year−13.3%
Dividend (yield on the price)1.3%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.18% → 11%
Compare Shanghai Menon Animal Nutrition Technology Co. Ltd. with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 625 stocks
Beats the industry median on 3/12 measures
Overall it trails its industry peers.
Valuation
Quality Score47 · Below median
Fair Value upside−68.0% · Bottom 25%
Profitability
Return on equity (12 months)6.9% · Below median
Return on assets6.6% · Above median
Net margin (12 months)7.6% · Above median
Operating margin (12 months)0.2% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)23.6% · Top 25%
Dividend yield (12 months)1.3% · Bottom 25%
Valuation Multiplesvs Packaged Foods median · lower = cheaper
P/E (12 months)38.4× · Priciest 25%
P/B2.60× · Priciest 25%
P/S (12 months)2.91× · Priciest 25%
EV/EBITDA20.6× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 35
FUTURE (revenue growth)100· sector 25
PAST (return on equity)28· sector 31
HEALTH (low debt)100· sector 96
DIVIDEND (yield)25· sector 55
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Shanghai Menon Animal Nutrition Technology Co. Ltd. (301156) overvalued or undervalued?
As of Nov 5, 2026, our model estimates a fair value of ¥3.32 versus a price of ¥10.38, about 68% lower (overvalued).
What is the fair value of 301156?
Our model-based fair value for Shanghai Menon Animal Nutrition Technology Co. Ltd. is ¥3.32 (as of Nov 5, 2026), built from audited fundamentals. The current price: ¥10.38.
What is the quality score of 301156?
Shanghai Menon Animal Nutrition Technology Co. Ltd. has a Quality Score of 47/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Shanghai Menon Animal Nutrition Technology Co. Ltd. (301156)?
Our model-based price target is the fair value of ¥3.32 (as of Nov 5, 2026) from 16 valuation models. Cautious scenario ¥2.69, optimistic scenario ¥4.46. It is a calculation from audited fundamentals, not an analyst target.
What is the Shanghai Menon Animal Nutrition Technology Co. Ltd. stock forecast for 2026?
Our models put fair value at ¥3.32, about 68% lower versus a price of ¥10.38 (overvalued). Cautious scenario ¥2.69, optimistic scenario ¥4.46. The calculation is refreshed regularly with new filings.
What is the revenue of Shanghai Menon Animal Nutrition Technology Co. Ltd. (301156)?
Shanghai Menon Animal Nutrition Technology Co. Ltd. reported trailing-twelve-month revenue of about 653M CNY (latest available figure, as of Nov 5, 2026).
Does Shanghai Menon Animal Nutrition Technology Co. Ltd. pay a dividend?
Shanghai Menon Animal Nutrition Technology Co. Ltd. currently shows a dividend yield of 1.26% relative to its recent price (as of Nov 5, 2026).
How much is the dividend of Shanghai Menon Animal Nutrition Technology Co. Ltd. (301156) and when is the ex-dividend date?
Shanghai Menon Animal Nutrition Technology Co. Ltd. pays a dividend of ¥0.131 per share a year, a dividend yield of 1.3%. The last ex-dividend date was May 29, 2026. The payout ratio is 48.5% of earnings. Our assessment: Watch coverage. The dividend isn’t fully covered by free cash flow or earnings, part of it is funded from reserves or debt. Fine for now, but worth watching: if it stays uncovered, the dividend could be cut.
What is the intrinsic value of Shanghai Menon Animal Nutrition Technology Co. Ltd. (301156)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Shanghai Menon Animal Nutrition Technology Co. Ltd. it is ¥3.32 per share (as of Nov 5, 2026), against a price of ¥10.38. It is the blended result of 16 valuation models in 6 families (Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Shanghai Menon Animal Nutrition Technology Co. Ltd. stock overvalued or undervalued in 2026?
As of Nov 5, 2026, 301156 trades above its calculated fair value: price ¥10.38, fair value ¥3.32, a gap of about −68% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 301156?
No. The price is what the market pays today (¥10.38); the fair value is what the company's own numbers justify (¥3.32). For Shanghai Menon Animal Nutrition Technology Co. Ltd. the two are ¥7.06 per share apart. That gap is exactly why we show both numbers side by side.
How much is Shanghai Menon Animal Nutrition Technology Co. Ltd. worth?
The market values Shanghai Menon Animal Nutrition Technology Co. Ltd. at about 1.9B CNY (market capitalisation, as of Nov 5, 2026). Per share that is ¥10.38; our models calculate a fair value of ¥3.32 per share.
What do the bullish and bearish scenarios say about 301156?
Our models span a range for Shanghai Menon Animal Nutrition Technology Co. Ltd.: cautious scenario ¥2.69, base ¥3.32, optimistic ¥4.46 per share (as of Nov 5, 2026, price ¥10.38). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 301156?
Shanghai Menon Animal Nutrition Technology Co. Ltd. trades at a price-to-earnings ratio of 38.4 (as of Nov 5, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥3.32 is built from several models across several years. Other multiples: P/B 2.6, P/S 2.9, EV/EBITDA 20.6.
How solid is the balance sheet of Shanghai Menon Animal Nutrition Technology Co. Ltd. (301156)?
Balance-sheet figures for Shanghai Menon Animal Nutrition Technology Co. Ltd. (as of Nov 5, 2026): return on equity 6.9%. They feed the Quality Score of 47/100, which measures business quality independently of the share price.
How far is 301156 from its 52-week high?
Shanghai Menon Animal Nutrition Technology Co. Ltd. trades at ¥10.38, about 35% below its 52-week high of ¥15.95 and 4% above the low of ¥9.96 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of ¥3.32 is for.
Which stocks are comparable to Shanghai Menon Animal Nutrition Technology Co. Ltd.?
From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, Foshan Haitian Flavouring and Food Company, The Kraft Heinz Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Shanghai Menon Animal Nutrition Technology Co. Ltd. stock attractive at the current price?
The data as of Nov 5, 2026: price ¥10.38, calculated fair value ¥3.32 (−68%), Quality Score 47/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 301156 calculated?
We run Shanghai Menon Animal Nutrition Technology Co. Ltd. through 16 models from 6 families: Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ¥3.32 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Shanghai Menon Animal Nutrition Technology Co. Ltd. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Shanghai Menon Animal Nutrition Technology Co. Ltd. (301156)?
The closing price on Nov 6, 2026 was ¥10.38. Our model-based fair value is ¥3.32, about 68% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Shanghai Menon Animal Nutrition Technology Co. Ltd. right now?
The price sits above even our optimistic bull case (¥4.46). The favourable scenario is already priced in. Weak quality (47/100) and above fair value at the same time, the margin of safety is missing on both counts.
Key figures of Shanghai Menon Animal Nutrition Technology Co. Ltd.
How large is the market capitalisation of Shanghai Menon Animal Nutrition Technology Co. Ltd. (301156)?
The market capitalisation of Shanghai Menon Animal Nutrition Technology Co. Ltd. is 1.9B CNY (≈ $285M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Shanghai Menon Animal Nutrition Technology Co. Ltd. (301156)?
The price-to-sales ratio of Shanghai Menon Animal Nutrition Technology Co. Ltd. is 2.91 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Shanghai Menon Animal Nutrition Technology Co. Ltd. (301156)?
Earnings per share at Shanghai Menon Animal Nutrition Technology Co. Ltd. are ¥0.2700 (price ÷ EPS = P/E 38.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Shanghai Menon Animal Nutrition Technology Co. Ltd. (301156)?
The dividend yield of Shanghai Menon Animal Nutrition Technology Co. Ltd. is 1.3% (payout 48.5%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Shanghai Menon Animal Nutrition Technology Co. Ltd. (301156)?
The net margin of Shanghai Menon Animal Nutrition Technology Co. Ltd. is 7.6% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Shanghai Menon Animal Nutrition Technology Co. Ltd. (301156)?
The return on equity (ROE) of Shanghai Menon Animal Nutrition Technology Co. Ltd. is 6.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Shanghai Menon Animal Nutrition Technology Co. Ltd. (301156)?
On an EBIT basis the return on assets of Shanghai Menon Animal Nutrition Technology Co. Ltd. is 8.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Shanghai Menon Animal Nutrition Technology Co. Ltd. (301156)?
The operating margin of Shanghai Menon Animal Nutrition Technology Co. Ltd. is 0.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Shanghai Menon Animal Nutrition Technology Co. Ltd. (301156)?
Revenue at Shanghai Menon Animal Nutrition Technology Co. Ltd. is growing +23.6% versus a year earlier (3y avg +5.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Shanghai Menon Animal Nutrition Technology Co. Ltd. (301156)?
Earnings per share at Shanghai Menon Animal Nutrition Technology Co. Ltd. are growing −68.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Shanghai Menon Animal Nutrition Technology Co. Ltd. (301156) generate?
The free cash flow of Shanghai Menon Animal Nutrition Technology Co. Ltd. is −51.4M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Shanghai Menon Animal Nutrition Technology Co. Ltd. (301156) hold?
Shanghai Menon Animal Nutrition Technology Co. Ltd. holds more cash than debt, 260M CNY net (fiscal year 2024). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Shanghai Menon Animal Nutrition Technology Co. Ltd. in the live analysis
One click puts Shanghai Menon Animal Nutrition Technology Co. Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 5, 2026